NCT06022276 2023-09-01
Nimotuzumab for EGFR-amplified Advanced Pan Solid Tumors
Tianjin Medical University Second Hospital
Phase NA Unknown
Clinical Trials
3 trialsNCT05717790 2023-02-08
Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma
Fourth Affiliated Hospital of Guangxi Medical University
Phase NA Recruiting
NCT01393080 2016-02-17
NSCLC
Tianjin Medical University Cancer Institute and Hospital
Phase NA Unknown